drugset / Trial / NCT03587961
Personalized Theratyping Trial
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to explore the use of off-label CFTR modulators that may affect CFTR function in patients with CFTR mutations that are not currently approved for these drugs.
Timeline
- Start
- 2019-08-01
- Primary completion
- 2027-01-01
- Completion
- 2027-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tezacaftor/Ivacaftor | Unknown | — | — |